Comments
Novartis to show diverse oncology franchise at ASCO
31.05.2012. | ZURICH (Reuters) - Swiss drugmaker Novartis is hoping key cancer data on both its marketed products as well as promising drugs in its early pipeline will show it can pack a punch in the oncology field at a major industry meeting later this week....
